Vaccine production for Foot and Mouth Disease Global Market
The global animal vaccines market is in its growth phase and is estimated to be worth $5.8 billion in 2013. It is expected to grow at a healthy CAGR of 8.1% to reach $8.6 billion by 2018. The animal vaccines market is segmented on the basis of products, animal diseases, and technologies that are involved in developing vaccines for veterinary administration. The global animal vaccines market, by products, is further segmented into seven segments, namely, companion animal vaccines, livestock, poultry, porcine, equine, aquaculture, and other animal vaccines. In 2012, livestock vaccines and porcine vaccines were two of the largest segments, which accounted for 63% of the market share, globally. The livestock vaccines market is further segmented into bovine vaccines and small ruminant vaccines, whereas the companion animal vaccines market is further segmented into canine vaccines and feline vaccines, CMRS
Research Objective
BTS'S research objective is to produce MDS vaccine in Ethiopia.. BTS'S Vaccine production Summarised BTS will produce FMD vaccine from virus used in suspension cultures of a Baby-Hampster Kidney (BHK) cell line. FMD virus(Aphoto) will be bio-farmed at large scale. This is possible as antibodies were removed from the serum in the culture medium by pretreatment of the serum with PEG. Virus will be partly purified and concentrated by a precipation-filtration-elution (PFE) process: virus is precipated with PEG, the precipated virus is collected (with 'filter-aid') on a filter and eluted by pumping a buffer solution through the of the system, virus is produced in growing BHK cells. filter cake. Adequate protection of cattle will be obtained with Al(OH)3-vaccines, which will be prepared from these AEI-inactivated antigens.
Complete Proposal is available for Investor and financial Grants Donors upon request.